Secondary peritonitis
- abscess
- bowel perforation
- ruptured appendix
- Drainage and debridement essential.
- Blood and peritoneal cultures recommended for any high-risk community-acquired (ICU/critically ill, diffuse peritonitis, delayed or inadequate source control) peritonitis, and all cases of healthcare-associated peritonitis. If source control achieved, cultures of perforated or gangrenous appendix offer no benefit.
- Duration of therapy:
Peri-operative therapy ≤ 24h:
- bowel injuries due to penetrating, blunt, or iatrogenic trauma with surgery within 12 hours of injury;
- acute perforations of stomach, duodenum, and proximal jejunum in absence of antacid therapy or malignancy with surgery within 24 hours;
- acute appendicitis without perforation, abscess, or peritonitis;
- ischemic, non-perforated bowel.
Adequate source control - 2 days post-op with laparoscopic; 4 days with open surgical approach; 7 days if bacteremic
Source control delayed or not performed – 5-7 days:
- Monitor the following to determine if antimicrobial therapy can be discontinued sooner:
- temperature
- WBC/differential
- return of GI function
- Persistent clinical evidence of infection after 5-7 days warrants diagnostic investigations (CT, US).
Usual Pathogens
Polymicrobial:
Enterobacterales
Anaerobes
Streptococcus spp
Community-acquired, low risk
Therapy | Dose | Duration |
Ceftriaxone | 1-2g IV daily | See Duration |
+ | ||
Metronidazole IV/PO | 500mg IV/PO q12h |
Alternative
Therapy | Dose | Duration |
Amoxicillin-clavulanate | 1.2g IV q6h | See Duration |
Penicillin and ceftriaxone allergy
Therapy | Dose | Duration |
Ciprofloxacin IV/PO | 400mg IV q12h/500mg PO bid | See Duration |
+ | ||
Metronidazole IV/PO | 500mg IV/PO q12h |
Community-acquired, high risk:
• ICU/critically ill
• diffuse peritonitis
• delayed or inadequate source control
or
Healthcare-associated
Therapy | Dose | Duration |
Piperacillin-tazobactam | 4.5g IV q8h or | See Duration |
3.375g IV q6h | ||
Micafungin | 100mg IV daily | |
If healthcare-associated and postoperative infection, add: | ||
Vancomycin | 15mg/kg IV q12h |
Penicillin allergy/multiple previous antibiotics/known ceftriaxone-resistant Gram negative organism
Therapy | Dose | Duration |
Meropenem | 500mg IV q6h | See Duration |
Micafungin | 100mg IV daily | |
If healthcare-associated and postoperative infection, add: | ||
Vancomycin | 15mg/kg IV q12h |
Oral switch therapy
- Switch to oral agents when tolerating oral intake and clinical improvement.
Therapy | Dose | Duration |
Amoxicillin-clavulanate | 875mg PO bid | See Duration |
Penicillin allergy
Therapy | Dose | Duration |
[Ciprofloxacin | 500mg PO bid | See Duration |
+ | ||
Metronidazole] | 500mg PO bid | |
or | ||
[TMP/SMX | 1 DS tab PO bid | See Duration |
+ | ||
Metronidazole] | 500mg PO bid |